Clinical Trials Directory

Trials / Completed

CompletedNCT01243034

Waist Circumference Measurements in Schizophrenic Patients

Variability of Waist Circumference Measurements at 3 Sites and Its Relationship With Cardiovascular Risk Factors in Patients With Schizophrenia

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Changhua Christian Hospital · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The prevalence of metabolic syndrome(MS) among pt's with schizophrenia has been reported to be high, ranging from 24 to 43% in males and 27 to 52% in females. Schizophrenic patients with MS have an increased incidence of DM, coronary heart disease and increased mortality from cardiovascular diseases. Central adiposity is highly correlated with the presence of hypertension, coronary heart disease, type 2 diabetes, and increased mortality risk. Waist circumference(WC) is a better indicator of abdominal obesity and a better predictor of CVD than either BMI or waist-to-hip ratio. However, currently there is no standard location for the measurement of WC. Objectives: 1. To compare the magnitude of WC measured at 3 sites ( immediately above the iliac crest, midpoint between the lowest rib and the iliac crest , umbilical level) in males and females. 2\. To examine the correlation of WC with Triglyceride, cholesterol, HDL, LDL and glucose.

Conditions

Timeline

Start date
2010-08-01
Primary completion
2011-07-31
Completion
2011-07-31
First posted
2010-11-18
Last updated
2019-02-01

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01243034. Inclusion in this directory is not an endorsement.